Showing results (681-690 of 834) with videos related to
Sort By:
Pageof 84
Lancet (London, England)|September 28, 2012
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysisBakhtawar K Mahmoodi, Kunihiro Matsushita, Mark Woodward, et al.Diabetes, Obesity & Metabolism|February 1, 2023
Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baselineJanet B McGill, Rajiv Agarwal, Stefan D Anker, et al.BMJ Open|December 16, 2025
Study protocol for the investigator-initiated Danish pragmatic randomised STENO INTEN-CT trial: does screening and intervention for subclinical coronary artery disease in type 2 diabetes reduce cardiovascular events?Kristian Løkke Funck, Britt Borregaard, Kenneth Egstrup, et al.Diabetologia|September 23, 2022
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Melanie J Davies, Vanita R Aroda, Billy S Collins, et al.Diabetes, Obesity & Metabolism|July 4, 2023
The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY studyPeter Rossing, Stefan D Anker, Gerasimos Filippatos, et al.Lipids in Health and Disease|September 26, 2023
Ceramides are decreased after liraglutide treatment in people with type 2 diabetes: a post hoc analysis of two randomized clinical trialsAsger Wretlind, Viktor Rotbain Curovic, Andressa de Zawadzki, et al.Kidney International Reports|June 15, 2026
Post-Hoc Analysis on the Effects of Vicadrostat/Empagliflozin by CKD Severity/Hypertension StatusRicardo Correa-Rotter, Peter Rossing, Maria Eugenia Canziani, et al.Kidney International|August 5, 2019
Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney diseasePeter Rossing, Geoffrey A Block, Melanie P Chin, et al.Diabetes Care|September 23, 2022
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Melanie J Davies, Vanita R Aroda, Billy S Collins, et al.Journal of General Internal Medicine|December 15, 2023
Effects of Dapagliflozin in Chronic Kidney Disease Across the Spectrum of Age and by SexMargaret K Yu, Priya Vart, Niels Jongs, et al.Pageof 84